Axol Bioscience
OtherCambridge, UKJan 2026
Axol Bioscience raised €2.4M in a funding round in Jan 2026. The company is based in Cambridge, UK. Investors in the round: BroadOak Capital Partners, Roslin Foundation. Data as of Nov 2026.
Amount raised
€2.4M
€2,408,809
Native amount
2,800,000 USD
Stage
Other
funding round
Investors
2
Provenance & confidence
High confidenceAmount
2,800,000 USD
ECB-at-date → €2.4M · rate 1.1624 on 2026-01-15
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Jan 2026
Round type
funding round
Amount (EUR)
€2.4M